This protocol addresses patients with a blood lead level below 44 mcg/dL who are presenting with significant symptoms of lead toxicity — a subset in which the symptom burden, not the lead level alone, guides the treatment decision.
Oral chelation therapy is indicated for those with a blood lead level below 44 mcg/dL if they have significant symptoms. The presence of clinically meaningful symptoms is the key criterion that triggers intervention at this lead level.
Management involves oral chelation therapy. The specific agent, dosing schedule, and monitoring parameters are detailed in the full structured protocol — only part of the approach is summarised here.
Lowering of the blood lead level. Note that while chelation may reduce the measurable lead burden, the full protocol addresses what to expect and monitor beyond the numeric target.
Oral chelation therapy is indicated for those with a blood lead level below 44 mcg/dL if they have significant symptoms.
However, although chelation therapy in children with blood lead levels between 20 and 44 mcg/dL may lower the levels, it has not been shown to reverse any neuropsychological effects.
View source ↗